Clindamycin is primarily used for gram-positive or anaerobic bacterial infections involving the skin, respiratory tract, or oral cavity. BCP encourages utilizing an FDA approved product whenever possible. However, we realize that in order to achieve patient compliance and a desired therapeutic outcome, a customized compounded preparation may be necessary. In compliance with FDA GFI-256, this medication must be patient specific in addition to the reason why compounding is necessary.
Log in to view pricing, submit office orders & patient prescriptions